Network origin in Youe Kong Shu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ.
32
| Subsidiary | Pharmaceuticals: Major | 32 |
| Holding Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Youe Kong Shu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| HIKMA PHARMACEUTICALS PLC | Pharmaceuticals: Generic | Director/Board Member | |
| EAGLE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| KADMON HOLDINGS, INC. | Biotechnology | Director/Board Member | |
| Brown University | College/University | Undergraduate Degree Doctorate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| YPSOMED HOLDING AG | Medical Specialties | Director/Board Member | |
| San Diego State University | College/University | Graduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Delaware | College/University | Undergraduate Degree | |
CenterLight Health System, Inc.
 CenterLight Health System, Inc. Medical/Nursing ServicesHealth Services CenterLight Health System, Inc. provides residential and community-based health care services. Its services include nursing, rehabilitation, medical , adult day health care, home health care, housing and music therapy. The company was founded by Bertha Alperstein in 1920 and is headquartered in Bronx, NY. | Medical/Nursing Services | Director/Board Member | |
BioMedInvest AG I
 BioMedInvest AG I Investment ManagersFinance BioMedInvest AG I invests in companies located in Switzerland, Germany, Austria, France and Italy. The fund targets companies operating in the fields of drug development, focusing less on diagnostics and medical technology. It acts as lead/co-lead investor and provides financing for start-up to later stage and spin-off capital requirements with an investment size of CHF1 - CHF10 million. | Investment Managers | Corporate Officer/Principal | |
Biotech Ventures GP Ltd.
 Biotech Ventures GP Ltd. Financial ConglomeratesFinance Part of Bellevue Group AG, Biotech Ventures GP Ltd. is a venture capital fund. The company is based in St. Peter Port, UK. | Financial Conglomerates | Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
National Association of Corporate Directors (Virginia)
 National Association of Corporate Directors (Virginia) Miscellaneous Commercial ServicesCommercial Services National Association of Corporate Directors provides online and print information services to directors of public companies. It offers in-boardroom education, evaluation, governance reviews, board composition and succession planning, board recruitment, ongoing advisory, insights, and analytics services. The company was founded in 1977 and is headquartered in Arlington, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member | |
binx health, inc.
 binx health, inc. Information Technology ServicesTechnology Services Binx Health, Inc. develops and provides in vitro point-of-care (POC) testing on diseases such as sexually transmitted infections, neonatal sepsis and hospital acquired infections. Its technology products include in diagnostic and immunoassay platform, rapid POC, and nucleic acid detection technology. The company was founded by John Clarkson in 2005 and is headquartered in Trowbridge, the United Kingdom. | Information Technology Services | Director/Board Member | |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Bellevue Asset Management (Venture Capital)
 Bellevue Asset Management (Venture Capital) Investment ManagersFinance Bellevue Asset Management (Venture Capital) is the venture capital arm of Bellevue Asset Management AG, a subsidiary of Bellevue Group AG (SW: BBN) headquartered in Zurich, Switzerland. The firm was founded in 1993. | Investment Managers | Private Equity Investor | |
Ipsen, Inc.
 Ipsen, Inc. Industrial MachineryProducer Manufacturing Ipsen, Inc. design and manufacture of industrial atmosphere and vacuum heat-treating systems and supervisory controls systems. It offers vacuum furnaces, atmosphere furnaces, and PdMetrics software platform. The company was founded by Harold Ipsen in 1948 and is headquartered in Cherry Valley, IL. | Industrial Machinery | Corporate Officer/Principal | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
Cyber X Designs LLC
 Cyber X Designs LLC Advertising/Marketing ServicesCommercial Services Part of Relevate Health Group, Inc., Cyber X Designs LLC operates as a digital healthcare marketing agency. The company is based in Rochelle Park, NJ. The company was founded in 1999 by Hans C. Kaspersetz. Cyber X Designs was acquired by Relevate Health Group, Inc. on December 21, 2020. | Advertising/Marketing Services | Director/Board Member | |
| ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BB Biotech Ventures | Chief Executive Officer | ||
Relevate Health Group, Inc.
 Relevate Health Group, Inc. Miscellaneous Commercial ServicesCommercial Services Relevate Health Group provides health marketing and deployment services. It operates the following companies: Healthcare Regional Marketing and Spirit Health Group. The company was founded in 2015 and is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Director/Board Member | |
Hikma Ventures Ltd.
 Hikma Ventures Ltd. Investment ManagersFinance Hikma Ventures Ltd. (Hikma Ventures) is a venture capital arm of Hikma Pharmaceuticals Plc founded in 2015. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member | |
Pureos Partners AG
 Pureos Partners AG Investment ManagersFinance Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland. | Investment Managers | Private Equity Investor | |
| NANOFORM FINLAND OYJ | Biotechnology | Director/Board Member | |
Binx Health Ltd.
 Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
Alentis Therapeutics AG
 Alentis Therapeutics AG Pharmaceuticals: MajorHealth Technology Alentis Therapeutics AG develops novel medications to treat advanced liver diseases and cancers. The company was founded by Neil Goldsmith on March 1, 2019 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| Eir Advisory LLC | Corporate Officer/Principal | ||
Eternatear, Inc.
 Eternatear, Inc. Miscellaneous Commercial ServicesCommercial Services Eternatear, Inc.is developing an OTC product that treats progressive dry eye. The company is headquartered in Raleigh, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Relevate Holdings LP
 Relevate Holdings LP Miscellaneous Commercial ServicesCommercial Services Part of Mountaingate Management Co LLC, Relevate Holdings LP is a company that provides business services. The company is based in Denver, CO. | Miscellaneous Commercial Services | Director/Board Member | |
Ariceum Therapeutics GmbH
 Ariceum Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| Fu Jen Catholic University | College/University | Undergraduate Degree Undergraduate Degree | |
Omeza Holdings, Inc.
 Omeza Holdings, Inc. Medical/Nursing ServicesHealth Services Omeza Holdings, Inc. provides healthcare services. The company is based in Sarasota, FL. Cynthia L. Flowers has been the CEO of the company since 2023. | Medical/Nursing Services | Chief Executive Officer | |
| LISATA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 32 |
| Switzerland | 9 |
| United Kingdom | 5 |
| France | 3 |
| Canada | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 10 |
| Commercial Services | 8 |
| Finance | 7 |
| Health Services | 3 |
Operational
| Director/Board Member | 184 |
| Corporate Officer/Principal | 71 |
| Independent Dir/Board Member | 54 |
| Chairman | 42 |
| Chief Tech/Sci/R&D Officer | 35 |
Most connected contacts
| Insiders | |
|---|---|
| Henry McKinnell | 35 |
| Scott Rocklage | 32 |
| Michael Bonney | 32 |
| Howard Lee | 27 |
| Alain B. Schreiber | 25 |
| Cynthia Flowers | 22 |
| Martin C. Münchbach | 20 |
| Anthony Altig | 19 |
| Robert Zerbe | 18 |
| Pedro Lichtinger | 16 |
| Mark Auerbach | 15 |
| Rachel Stahler | 14 |
| Peter E. Grebow | 12 |
| Linda E. Amper | 11 |
| Francois-Xavier Frapaise | 11 |
- Stock Market
- Insiders
- Youe Kong Shu
- Company connections
